DB
Danielle Brill Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
41%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Credit Services
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $105 |
12%
upside
| 3 | +53% |
0
%
| 10 Nov ‘25 24 days ago |
|
|
|
Buy
Maintained
| $114 |
22%
upside
| 2 | +28% |
0
%
| 10 Nov ‘25 24 days ago |
|
|
|
Buy
Reiterated
| $172 |
12%
upside
| 2 | +8% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $80 |
7%
upside
| 2 | +28% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $535 |
15%
upside
| 2 | +23% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Hold
Initiated
| $16 |
30%
downside
| 1 | -42% |
–
| 14 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $47 |
68%
upside
| 1 | +40% |
0
%
| 14 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $56 |
25%
upside
| 1 | +30% |
0
%
| 14 Oct ‘25 1 month ago |
|
|
|
Market Perform
Initiated
| – | – | 1 | – |
–
| 3 Sep ‘25 3 months ago |
|
|
|
Buy
Initiated
| $48 |
25%
upside
| 1 | +8.6% |
0
%
| 21 Jul ‘25 4 months ago |
|
|
|
Buy
Initiated
| $64 |
201%
upside
| 1 | -3.1% |
0
%
| 21 Jul ‘25 4 months ago |
|
|
|
Buy
Initiated
| $30 |
2%
upside
| 1 | +88% |
0
%
| 21 Jul ‘25 4 months ago |
|
|
|
Buy
Initiated
| $24 |
15%
upside
| 1 | +25% |
0
%
| 21 Jul ‘25 4 months ago |
|
|
|
Strong Buy
Upgraded
| $52 |
125%
upside
| 1 | +216% |
0
%
| 10 Dec ‘24 11 months ago |
|